A novel manganese complex LMnAc selectively kills cancer cells by induction of ROS-triggered and mitochondrial-mediated cell death by unknown
SCIENCE CHINA 
Life Sciences 
© The Author(s) 2014. This article is published with open access at link.springer.com life.scichina.com   link.springer.com 
                  
*Corresponding author (email: jinggao@ujs.edu.cn) 
• RESEARCH PAPER • October 2014  Vol.57  No.10: 998–1010 
 doi: 10.1007/s11427-014-4682-6 
A novel manganese complex LMnAc selectively kills cancer cells by 
induction of ROS-triggered and mitochondrial-mediated cell death 
LI Xiang1, ZHAO KaiDi1, GUO WenJie1, LIU Xu1, LIU Jia1, GAO Jing1*, 
CHEN QiuYun2 & BAI YiDong3 
1School of Pharmacy, Jiangsu University, Zhenjiang 212013, China; 
2School of Chemistry & Chemical Engineering, Jiangsu University, Zhenjiang 212013, China; 
3Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA 
Received April 21, 2013; accepted November 8, 2013; published online June 13, 2014 
 
We previously identified a novel synthesized metal compound, LMnAc ([L2Mn2(Ac)(H2O)2](Ac) (L=bis(2-pyridylmethyl) 
amino-2-propionic acid)). This compound exhibited significant inhibition on cancer cell proliferation and was more selective 
against cancer cells than was the popular chemotherapeutic reagent cisplatin. In this study, we further investigated the under-
lying molecular mechanisms of LMnAc-induced cancer cell death. We found that LMnAc achieved its selectivity against can-
cer cells through the transferrin-transferrin receptor system, which is highly expressed in tumor cells. LMnAc triggered cancer 
cells to commit autophagy and apoptosis, which was mediated by the mitochondrial pathway. Moreover, LMnAc disrupted 
mitochondrial function, resulting in mitochondrial membrane potential collapse and ATP reduction. In addition, LMnAc in-
duced intracellular Ca2+ overload and reactive oxygen species generation. Interestingly, its anticancer effect was significantly 
reduced following pretreatment with the antioxidant N-acetyl cysteine, indicating that reactive oxygen species triggered cell 
death. Altogether, our data suggest that LMnAc appears to be a selectively promising anticancer drug candidate.  
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Following the landmark discovery of the biological activity 
of cisplatin [1], metal-based compounds have offered possi-
bilities for the design of therapeutics to study and treat a 
variety of human diseases. To date, cisplatin remains one of 
the most effective anticancer drugs in clinical use, while 
more and more novel metal-based anticancer complexes 
have been and are being developed [25]. In recent years, 
much research has focused on Fe, Ru, Os, and, V. These 
studies have demonstrated that inducing ROS and cell death 
is a well-known mechanism of bioinorganic complexes [6]. 
Of all the metals, manganese (Mn), a required cofactor 
for many ubiquitous enzymes [7], is an essential trace ele-
ment that plays a central role in the biochemistry and physi-
ology of many living organisms. Simple Mn(II) salts have 
been reported to exert anti-proliferative effects on several 
cancer cell lines generally by induction of apoptotic cell 
death [8]. Moreover, the transport mechanism of Mn(II) in 
vivo may make Mn(II)-based compounds possible tu-
mor-targets [5,9]. Recently, combining Mn(II) with other 
functional molecules has become a new strategy for the 
development of potent anti-tumor compounds. Ligands can 
significantly alter biological properties by limiting the ad-
verse effects of metal ion overload and facilitate metal ion 
re-distribution [10]. For example, Mn(II) complexes con-
taining thiosemicarbazone, hydrazone groups or chrysin 
were reported to have obvious anti-tumor effects [5,11,12]. 
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N-allyl di(picolyl)amine (L), used as a ligand in this study, 
has been reported to be both active against the proliferation 
of cancer cells and capable of complexing Mn(II) [13]. In 
addition, this compound is highly stable [13].  
Of note, cancer is associated with programmed cell death 
(PCD), which plays a crucial role in the development and 
homeostasis of multicellular organisms [14]. Apoptosis, 
type I PCD, targeting malignant cells has always been the 
aim of anticancer therapies [15]. Most antitumor therapies 
including chemotherapy primarily act by inducing apoptosis 
in cancer cells; however, defects in apoptosis programs may 
cause resistance [1618]. Autophagy, type II PCD, is dis-
tinct from apoptosis [1921], and is a cellular suicide path-
way that operates by digestion of essential cellular proteins 
[22]. More importantly, some investigations have demon-
strated that the co-regulation of both apoptosis and autoph-
agy can participate in mammalian cell death [23]. It has 
reported that autophagy increases the cytotoxicity of irradi-
ation in apoptosis-deficient cells, demonstrating the ability 
of autophagy to overcome resistance to apoptosis in cancer 
cells [24]. Moreover, new insights into the molecular 
mechanisms of autophagy are now leading to the discovery 
of exciting new potential drug targets [25]. Other reports 
have further pointed out that apoptosis and autophagy may 
be interconnected and even simultaneously regulated by the 
same trigger such as reactive oxygen species (ROS) and 
Ca2+ [26,27]. 
In addition, mitochondria are the primary site of ROS 
generation within cells and are also sensitive targets for 
ROS [28]. Several studies have shown that the global shut-
down of mitochondrial function under conditions of oxida-
tive stress could contribute to apoptosis [29,30]. During 
apoptosis, mitochondrial dysfunction is induced, resulting in 
several patterns of mitochondrial change, including collapse 
of the mitochondrial transmembrane potential, reduction of 
intracellular ATP levels and intracellular Ca2+ overload 
[29,31], which are also involved in autophagy. Furthermore, 
the fact that mitochondria play a key role in the regulation 
of cell death pathways makes them an attractive target for 
cancer chemotherapy [32]. 
It has been reported previously that newly synthesized 
Mn(II) complex LMnAc ([L2Mn2(Ac)(H2O)2](Ac) (L= 
bis(2-pyridylmethyl)amino-2-propionic acid)) exhibited good 
antitumor activity, but the mechanism remains unclear [33]. 
Therefore, the aim of the present study was to analyze the 
possible mechanism of LMnAc-induced cell death and its 
antitumor effect. This was assessed by investigating the 
relationship between cancer cell death and mitochondrial 
dysfunction. 
1  Materials and methods 
1.1  Materials 
Compound LMnAc was synthesized by Professor Chen 
QiuYun at Jiangsu University (China). GFP-LC3 plasmid 
was generously provided by Professor Qin ZhengHong at 
Soochow University (China). 3-[4,5-dimehyl-2-thiazolyl]- 
2,5-diphenyl-2H-tetrazolium bromide (MTT) was pur-
chased from Amresco (USA). 5,5′,6,6′-tetrachloro-1,10,  
3,30-tetraethylbenzimidazolylcarbocyani-n-eiodide (JC-1), 
Fluo-3AM, and lipofectamine 2000 were bought from Invi-
trogen (USA). Hoechst 33342, 3-MA, CCCP and mono-
dansylcadaverine (MDC) were purchased from Sigma-  
Aldrich (USA). Culture medium (DMEM/1640), trypsin 
and EDTA-2·Na were purchased from Gibco (USA). Fetal 
bovine serum was obtained from Sijiqing Biological Engi-
neering Materials (China). DCFH-DA, NAC and Lyso- 
Tracker Red were bought from Beyotime Institute of Bio-
technology (China). Antibodies against TfR1, DMT-1, cy-
tochrome c (Cyto C), pro-caspase9, LC3, Beclin-1, and 
β-actin were from Abcam (UK). All other chemicals were 
of high purity from commercial sources. 
1.2  Cell culture 
Four human cancer cell lines—the cervical cancer cell line 
HeLa, glioma cell line U251, hepatoma cell line HepG2, 
lung cancer cell line A549 and human liver cell line 
WRL-68—were obtained from the Cancer Cell Repository 
(Shanghai Cell Bank). Cells were maintained in RPMI-1640 
medium and DMEM medium (Gibco) supplemented with 
10% (v/v) fetal bovine serum and antibiotics (100 U mL1 
penicillin and 100 U mL1 streptomycin), and maintained at 
37°C in a humidified atmosphere of 5% (v/v) CO2. 
1.3  MTT assay to evaluate cell viability and selectivity 
Cell viability was evaluated by means of the MTT assay 
[34]. Briefly, cells were plated at a density of approximately 
4×103 viable cells per well in 96-well plates. Various con-
centrations of the compound were used to treat cells in 
quintuplicate. After incubation for the indicated time, the 
MTT assay was performed to measure cell viability using a 
96-well plate reader (Spectra MAX 190, Molecular Devices 
Corporation, USA). 
1.4  Western blot analysis to determine protein levels  
Following incubation with LMnAc, 2×106 cells were col-
lected and centrifuged at 1000×g, washed with phosphate 
buffered saline (PBS), lysed in 100 μL precooled lysis buff-
er containing 0.5% (v/v) Triton X-100, 100 mmol L1 
Tris-HCl, 150 mmol L1 NaCl, 0.1 U mL1 aprotinin for  
30 min on ice and centrifuged at 12000×g for 2 min. The 
supernatant was collected followed by protein concentration 
determination using the NJJC protein assay kit with bovine  
serum albumin (BSA) as a standard control. Samples were  
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mixed with a double volume of sample buffer (62.5 mmol L1 
Tris, pH 6.8, 2% (w/v) SDS, 5% (v/v) mercaptoethanol, 1% 
(w/v) bromophenol blue, and 25% (v/v) glycerol) and 
boiled for 5 min. Twenty micrograms of protein was elec-
trophoresed on a 10% (w/v) SDS-polyacrylamide gel. Pro-
tein was transferred to a polyvinylidene-difluoride (PVDF) 
membrane (Bio-Rad, USA), blocked with 5% (w/v) skim 
milk, and incubated overnight at 4°C with TfR-1 (1:500), 
DMT-1 (1:500), pro-caspase9 (1:500), LC3 (1:2000), Be-
clin-1 (1:1500) and β-actin (1:2000) primary antibodies 
diluted in PBS+Tween 20 (PBST). After being washed with 
PBST, the membrane was incubated in the appropriate 
HRP-conjugated secondary antibody (diluted 1:2000 in 
PBST) at room temperature for 2 h, and incubated with  
enhanced chemiluminescence reagent (ECL) solution for  
3 min and visualized. 
The mitochondrial proteins were isolated as follows. Al-
iquots of 2×105 A549 cells were seeded onto six-well plates, 
and harvested following exposure to LMnAc at different 
time points. Lysates were centrifuged at 12000×g at 4°C for 
15 min to obtain the supernatants (cytosolic extracts free of 
mitochondria) and the pellets (fraction that contains mito-
chondria). The pellets were subjected to Western blotting as 
above. Membranes were incubated overnight at 4°C with 
Cyto C (1:500). 
1.5  MTT assay to analyze the effect of Fe on the inhi-
bition of LMnAc 
A549 cells were plated at a density of approximately 4×103 
viable cells per well in 96-well plates. Cells were pretreated 
with 10 μmol L1 DFO (deferoxamine) and 100 μmol L1 
ferric citrate. Various concentrations (315 µmol L1) of 
LMnAc were used to treat cells in quintuplicate. After in-
cubation for various times, the MTT assay was performed. 
1.6  Morphology of cells 
H2B-labeled HeLa cells (stable cell line) were generously 
provided by Professor Li ChaoJun at Nanjing University 
(China). The morphological changes of H2B-GFP-labled 
HeLa cells were observed under the Nikon Ti-E microscope 
using the live cell station (LCS), which can supply CO2, 
maintain temperature and a fixed position. The H2B- 
GFP-labled HeLa cells with 10 μmol L1 LMnAc were ob-
served for 24 h. Bright field and fluorescence images of 
cells were recorded and analyzed. 
1.7  Hoechst 33342 staining to observe apoptotic nuclei 
A549 cells were treated with LMnAc and the nuclei were 
stained with Hoechst 33342 [35]. Morphological changes 
were analyzed under a fluorescence microscope. 
1.8  AnnexinV/PI staining to measure the rate of apop-
tosis 
Briefly, following treatment with LMnAc for 0–36 h, A549 
cells (1×106) were harvested and washed twice with 
ice-cold PBS. Phosphatidylserine exposed on the outside of 
apoptotic cells was determined using the Annexin V-FITC 
apoptosis kit (Molecular Probes, USA). A 5 µL aliquot of 
Annexin V-FITC and 10 µL Propyl iodide (PI) buffer were 
added to 100 µL of 1×Annexin V-FITC binding buffer; cells 
were then incubated at room temperature for 15 min in the 
dark. After adding 400 µL of 1×AnnexinV-FITC binding 
buffer, the cells were analyzed by flow cytometry (Becton 
Dickinson FACSCalibur, USA). 
1.9  MDC staining to detect acidic vesicular organelles  
As a marker of autophagy, the volume of the cellular acidic 
compartment was visualized by MDC staining, as described 
previously [36]. A549 cells (2×104) were seeded onto 
24-well plates and cultured for 24 h. After pretreatment with 
LMnAc for 24 h, cells were incubated with 50 mmol L1 
MDC at 37°C for 15 min, washed with PBS and then ob-
served under a fluorescence microscope. 
1.10  Lyso-Tracker Red staining to evaluate the activity 
of lysosomes  
A549 cells treated with LMnAc for 24 h were incubated 
with 50 nmol L1 Lyso-Tracker Red at 37°C for 30 min, 
washed with PBS and then observed with a fluorescence 
microscope. 
1.11  GFP-LC3 plasmid transfection to examine LC3 
protein aggregation 
A549 cells were transfected with 1 μg of GFP-LC3 ex-
pressing plasmid in each well of a 24-well plate using 
lipofectamine 2000. After 4 h, cells were treated with 
LMnAc, and the fluorescence of GFP or GFP-LC3 was 
viewed under a fluorescence microscope. 
1.12  JC-1 staining to measure mitochondrial mem-
brane potential (MMP) 
MMP was determined using the fluorescent dye JC-1 [37]. 
A549 cells were seeded in 96-well plates or on chamber 
slides and treated with LMnAc at the indicated concentra-
tions and times. Fluorescence intensity was measured im-
mediately following JC-1 staining (5 mg mL1 of JC-1 at 
37°C for 30 min) by fluorescence spectrometry (Molecular 
Devices Corporation, USA) or observed using a fluores-
cence microscope (excitation 488 nm/emission 535 nm for 
JC-1 green and excitation 488 nm/emission 595 nm for JC-1 
red). 
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1.13  Luciferase assay to determine intracellular ATP 
content 
The ATP content was determined by the luciferin-luciferase 
method [38]. Cells were harvested following different 
treatments and assayed for ATP using the Beyotime chemi-
cal luciferase ATP assay kit. 
1.14  Fluo-3-AM staining to elevate intracellular free 
Ca2+ concentrations ([Ca2+]i) 
[Ca2+]i was determined using the fluorescent dye 
Fluo-3-AM [39]. A549 cells treated with LMnAc, were 
loaded with 3 μg mL1 Fluo-3-AM at 37°C for 30 min, 
washed with PBS and the fluorescence of [Ca2+]i was 
viewed under a fluorescence microscope and analyzed by 
flow cytometry. 
1.15  DCFH-DA staining to detect intracellular ROS 
ROS were measured with the non-fluorescent probe 
DCFH-DA. DCFH-DA can passively diffuse into cells and 
be deacetylated by esterase to form non-fluorescent 
2,7-dichlorofluorescein (DCFH). In the presence of ROS, 
DCFH reacts with ROS to form the fluorescent product 
DCF which is trapped inside the cells. Analysis of ROS 
production was performed according to a reported method 
[40]. Briefly, A549 cells treated with LMnAc were washed 
with ice-cold PBS and incubated with 10 μmol L1 
DCFH-DA at 37°C for 20 min. DCF fluorescence intensity 
was detected by fluorescence spectrometry (Spectra MAX  
GEMINI, Molecular Devices, USA) or observed by    
fluorescence microscopy (excitation 488 nm/emission   
535 nm). 
1.16  Statistical analysis 
Differences among all groups were analyzed by one-way 
ANOVA, followed by the SNK-q-test using SPSS 10 soft-
ware. A P-value <0.05 was considered statistically signifi-
cant. 
2  Results 
2.1  LMnAc-induced selective inhibition in cancer cell 
viability  
LMnAc exerted good antitumor activity, with values of 
IC50 for the four cancer cell lines ranging from 8 to 36 
μmol L1 (Table 1). Cells were treated with different (3–15 
μmol L1) doses of the complex for 24, 36, 48 h, and it was 
found that the inhibition of A549 cell proliferation was not 
only dose-dependent, but also time-dependent (Figure 1A), 
which was confirmed by morphological observations (Fig-
ure 1B) showing cell body shrinkage and cell number re-
duction at 24 h after exposure to 10 or 100 μmol L1 
LMnAc. 
To test the selectivity of LMnAc, the liver cancer cells 
(HepG2) and the non-malignant liver epithelial cells 
(WRL-68) were used. LMnAc showed significant selectivi-
ty towards HepG2 over WRL-68 (Figure 2A) when com-
pared with cisplatin (Figure 2B). The preferential toxicities  
 
 
Figure 1  Dose- and time-dependent effect of LMnAc on cell proliferation of A549 cells. A, A549 cells were exposed to LMnAc (3–15 µmol L1) or cis-
plain (10 µmol L1). Each column represents the mean of the data from five independent experiments ( x ±SD, N=5, *P<0.05 vs. control). B, Morphological 
changes were induced by LMnAc in A549 cells for 48 h and observed.  
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Table 1  IC50 values of LMnAc on HeLa, U251, A549 and HepG2 cells 
for 48 ha) 










a) Data represent the mean±SD of three independent experiments. IC50 
values were determined graphically from the growth inhibition curves 
obtained after a 48 h exposure of cells to LMnAc, using the software from 
the China Pharmaceutical University. 
towards cancer cells over non-cancer cells suggest strong 
potential of this compound towards an antitumor applica-
tion. 
2.2  LMnAc is transported into cells through the 
Tf-TfR system 
Because of the high expression of TfR and DMT on tumor  
cells, the selectivity of LMnAc may be due to its transport 
mechanism. We can see from Figure 3A that TfR1 expres-
sion in HepG2 cells was higher than WRL-68 cells, while 
DMT1 levels were almost equal. In addition, as shown in 
Figure 3B and C, ferric citrate pretreatment can reduce 
TfR1 levels and inhibit the effect of LMnAc on A549 cells, 
while DFO can promote it (Figure 3B and D). 
2.3  LMnAc induces cell cycle arrest and apoptosis 
through the mitochondrial pathway 
As indicated in Figure 4A, untreated H2B-labeled HeLa 
cells were shown in an active dividing state suggesting that 
many of the cells were at metaphase. However, after incu-
bation with 10 μmol L1 LMnAc for 12 h, the cells shrank, 
chromatin condensation occurred (Figure 4B) and the fea-
tures of metaphase nuclei decreased drastically compared 
with untreated H2B-labeled HeLa cells (Figure 4C). With 




Figure 2  LMnAc exhibited selective inhibition on cancer cell proliferation. HepG2 cells and WRL-68 cells were treated with different concentrations of 
LMnAC (A) or cisplain (B) for 48 h ( x ±SD, N=5, *, P<0.05). 
 
Figure 3  LMnAc was transported into cancer cells through the transferrin-transferrin receptor system. A, Expression of TfR-1 and DMT-1 in HepG2 and 
WRL-68 cells. B, DFO/ferric citrate promoted/decreased the expression of TfR-1. Cells were pretreated with DFO (10 µmol L1) (C) or ferric citrate (100 
µmol L1) (D) for 24 h, then treated with different concentrations of LMnAc for 24 h ( x ±SD, N=5, *, P<0.05 vs. control). 
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parts coupled with the emergence of apoptotic bodies. The 
percentage of cells that showed apoptotic nuclei increased 
in a time-dependent manner (Figure 4D).  
The A549 cells stained with Hoechst 33342 exhibited 
similar microscopic results (Figure 5A, indicated by arrows). 
To further confirm the ratio of apoptosis, cells treated with 
LMnAc were analyzed by FACS using Annexin V/PI stain-
ing. As shown in Figure 5B and C, the apoptotic cells were 
significantly increased following a 36 h treatment (47.2 %, 
lower right).  
To further examine the pathway of apoptosis, Cyto C 
content in the cytosol, a marker of mitochondrial-mediated 
apoptosis, was examined by Western blot analysis. As 
shown in Figure 5D and E, both Cyto C in mitochondria and 
pro-caspase9 in the cytosol decreased after being exposed to 
LMnAC for 12 h, indicating that LMnAc-induced apoptosis 
 
 
Figure 4 (color online)  LMnAc induced apoptosis in H2B-labled HeLa cells. Morphological changes of cells and nuclei using the live cell system (LCS) 
were observed after cells were exposed to 20 mol L1 of LMnAc. This process lasted for over 24 h. Cells that exhibited reduced nuclear size, appeared 
shrunken, had intense fluorescence, nuclei fragmentation were apoptotic. A, Control. B, 20 mol L1 LMnAc. a and e: 6 h; b and f: 12 h; c and g: 18 h; d and 
h: 24 h. ad: bright field images; ef: fluorescence images of nuclei. Metaphase (C) and apoptotic (D) nuclei were counted from three fields of view at each 
time point and the percent was calculated ( x ±SD, N=3, *, P<0.05 vs. control). 
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Figure 5 (color online)  LMnAc induced apoptosis in A549 cells via the mitochondrial pathway. A, The cells were treated with 5, 10, and 15 μmol L1 
LMnAc for 24 h, stained with Hoechst 33342, and then images of morphology and nuclei were captured with a Nikon Ti-E PFS microscope. a: control; b: 5 
μmol L1; c: 10 μmol L1; d: 15 μmol L1. B, A549 cells were treated with 10 μmol L1 LMnAc at different time points. The cells were then stained with 
Annexin V-FITC and propidium iodide in the dark and analyzed by flow cytometry. a: control; b: 12 h; c: 24 h; d: 36 h. C, Apoptosis rates were calculated 
using three independent experiments ( x ±SD, N=3, *, P<0.05 vs. control). D, CytoC release from mitochondria. E, Pro-casepase 9 levels decreased. 
through the mitochondrial pathway. 
2.4  LMnAc-induced autophagic cell death 
In A549 cells, the LMnAc-treated groups showed greater 
fluorescence intensity and much more MDC-labeled parti-
cles than the control group (Figure 6A), indicating that 
LMnAc increased MDC recruitment to autophagosomes in 
the cytoplasm. Similarly, the activity of lysosomes was also 
enhanced in LMnAc-treated groups as compared to the con-
trol group (Figure 6B), which occurs normally in autophagy. 
Because LC3 is a specific marker for autophagosome 
formation [41], GFP-LC3 plasmids were transfected into 
A549 cells and cells with GFP-LC3 vacuoles (dots) were 
observed using a fluorescence microscope. In Figure 6C, 
formation of GFP-LC3 vacuoles (dots) in A549 cells was 
viewed after treatment with 5–15 μmol L1 LMnAc for 24 h. 
Consistent with the results of MDC staining and GFP-LC3 
vacuole formation, elevated Beclin-1 and conversion of 
LC3-I to LC3-II after treatment were also detected (Figure 
6D). Furthermore, it was found that after pretreatment with 
3-MA, an inhibitor of autophagy, cell death was reduced in 
a dose-dependent manner (Figure 6E). This indicated that 
autophagy may be the main cell death pathway involved 
following 5–10 μmol L1 LMnAc incubation for 24 h in 
A549 cells.
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Figure 6 (color online)  LMnAc induced autophagy in A549 cells. MDC fluorescence (A), lysosome activity (B) enhanced and induced GFP-LC3 vacuole 
(dots) formation (C) after treatment with 5, 10 and 15 μmol L1 LMnAc. a: control; b: 5 μmol L1; c: 10 μmol L1; d: 15 μmol L1. Beclin-1 expressions, LC3 
expression and conversion of LC3-I to LC3-II were analyzed by Western blotting after treatment with 10 µmol L1 LMnAc for 12, 24 and 36 h (D). 3-MA 
pretreatment reduced cell death and autophagy induced by LMnAc. Cells were pretreated with 3-MA (10 mmol L1) for 2 h, then treated with LMnAc for  
24 h. The MTT assay was used to evaluate cell viability (E) ( x ±SD, N=5, *, P<0.05 vs. control). 
2.5  LMnAc-induced mitochondrial dysfunction: de-
creased MMP and intracellular ATP levels 
To examine whether the compound affected mitochondrial 
function, MMP was examined by observing the relative 
ratio in red and green fluorescence of JC-1. Data of fluo-
rescence spectrometry revealed that the ratio between red 
and green fluorescence intensity was decreased in the 36-h 
and 48-h groups, indicating that exposure to the compound 
for more than 36 h resulted in depolarization of the mito-
chondrial membrane (Figure 7A). Treatment with 5, 10, and 
15 μmol L1 LMnAc for 48 h led to MMP collapse, showing 
enhanced green intensity and reduced red intensity of JC-1 
(Figure 7B). However, MMP increased after 5–10 μmol L1 
LMnAc incubation for 24 h, which may be a result of stress. 
MMP is the driving force for ATP synthesis. Loss of 
MMP is expected to cause decreases in ATP levels in cells. 
The cellar ATP level is an important determinant for cell 
death. To evaluate whether mitochondrial dysfunction was 
involved, levels of cellular ATP were determined after 
LMnAc treatment. As shown in Figure 8, LMnAc induced a 
time-dependent decrease in cellular ATP levels. Treatment 
with 10 μmol L1 LMnAc for 24 h showed significant ATP 
depletion compared with the control group, which resulted 
in a decrease from 1.88 to 1.44 nmol per mg protein. 
2.6  LMnAc-induced intracellular Ca2+ overload 
Calcium is a key regulator of mitochondrial function and 
acts at several levels within the organelle, such as stimulat-
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Figure 7  LMnAc induced MMP collapse in A549 cells. A, Dose and time-dependent decrease of red/green fluorescence ratio of JC-1 after treatment with 
LMnAc in A549 cells ( x ±SD, N=5, *, P<0.05 vs. control). B, Cells were exposed to 5, 10, and 15 mol L1 LMnAc for 48 h. The change in JC-1 fluores-
cence in mitochondria was visualized using the Nikon fluorescence microscope. a: control; b: CCCP; c: 5 mol L1; d: 10 mol L1; e: 15 mol L1. 
 
Figure 8  LMnAc decreased intracellular ATP levels. Time-dependent 
depletion of intracellular ATP following treatment with 10 μmol L1 
LMnAc in A549 cells at 12, 24, and 36 h. ATP levels were measured with 
the luciferin-luciferase assay ( x ±SD, N=3, *, P<0.05 vs. control). 
ing ATP synthesis. The [Ca2+]i was determined using the 
fluorescent dye Fluo-3-AM. The LMnAc-treated groups 
(5–15 μmol L1) showed higher fluorescence intensity in 
A549 cells compared with the control group (Figure 9A), 
with the relative intensity increasing only after 10 μmol L1 
LMnAc treatment for 24 h (Figure 9B), which indicated 
intracellular Ca2+ overload. 
2.7  LMnAc-induced intracellular ROS increase 
Mitochondria are the primary site of ROS generation within 
the cells and are also sensitive targets for ROS. To deter-
mine whether ROS were important in cell death induced by 
LMnAc, intracellular ROS levels were observed under a 
fluorescence microscope and measured by fluorescence 
spectrometry after being labeled with DCFH-DA. As shown 
in Figure 10A and B, treatment with 5–15 μmol L1 LMnAc 
for 24 h led to an increase in ROS. ROS levels increased 
significantly with the detection of higher fluorescence in-
tensities compared with the control group, and the level of 
increase was time-dependent (Figure 10C). 
To confirm whether ROS were essential for LMnAc-  
induced cell death, cells were pretreated with NAC for 30 min,  
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Figure 9  LMnAc induced intracellular Ca2+ overload in A549 cells. A, Cells were treated with 5, 10, and 15 μmol L1 of LMnAc for 24 h and fluorescence 
images were captured. a: control; b: 5 μmol L1; c: 10 μmol L1; d: 15 μmol L1. B, Intracellular Ca2+ levels were detected by FACS. Bluish violet peak: con-
trol; green peak: 6 h; purple peak: 12 h; blue peak: 24 h. 
 
Figure 10  LMnAc triggered ROS generation in A549 cells. A, Cells were treated with 5, 10, and 15 μmol L1 of LMnAc for 24 h. Fluorescence images 
were captured. a: control; b: 5 μmol L1; c: 10 μmol L1; d: 15 μmol L1. B, Fluorescence intensity was detected using the spectrophotofluorometer. C, Cells 
were treated with 10 μmol L1 of LMnAc for 6, 12, and 24 h. Fluorescence intensity was detected using the spectrophotofluorometer. D, LMnAc-induced 
ROS increases were attenuated by NAC ( x ±SD, N=3, *, P<0.05 vs. control). 
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and then treated with LMnAc for 24 h. The inhibition rate 
of LMnAc-treated cells was significantly decreased follow-
ing pretreatment with NAC. This suggests that the toxicity 
of LMnAc was reduced by NAC (Figure 10D). These data 
demonstrate that LMnAc-mediated cell death may be relat-
ed to its ability to elevate ROS levels. 
3  Discussion  
The potential of metal-based anticancer agents has not been 
fully investigated and realized until the successful applica-
tion of cisplatin. Therefore, a series of manganese-   
compounds were synthesized to verify whether they could 
be used as anticancer drugs. From these studies, LMnAc 
was selected for further analysis.  
In the present study, LMnAc showed activity against four 
human tumor cells of various origin. Further experiments 
indicated that LMnAc exhibited a dose- and time-dependent 
inhibition on A549 cells. Thus, LMnAc may be used as a 
potential candidate agent against cancer cells due to its se-
lectivity. This compound exhibited superb selective and 
targeted characteristics against cancer cells over the popular 
chemotherapeutic reagent cisplatin. It is likely that LMnAc 
achieved its selectivity over cancer cells through specific 
binding and subsequent import via interaction between 
Mn(II) ions on the compound and divalent metal transporter 
(DMT-1) and TfR [8], which are highly expressed in some 
tumor tissues [42]. 
Most of the metal-complexes such as copper or cisplatin 
complexes have shown not only activity for DNA binding 
and cleavage, but also the ability to induce cell cycle arrest 
and apoptosis [12,43,44]. However, previous studies on 
LMnAc have shown moderate DNA binding [33]. In addi-
tion, manganese-complexes can induce apoptosis via the 
mitochondrial pathway in various cancer cells, which can 
induce mitochondrial membrane depolarization followed by 
Cyto C release to the cytoplasm and caspases 3/7 activation 
[45]. In agreement with these studies, LMnAc was able to 
induce characteristics of apoptosis including nuclei con-
densation and apoptotic body emergence, which occurred 
through the mitochondrial pathway. 
Meanwhile, it has been reported that autophagy plays a 
role in Mn nanoparticle-induced cell death [46]. The fol-
lowing characteristics of autophagy were also observed in 
the present study: formation of AVO and GFP-LC3 vacu-
oles, enhancement of lysosomal activity, increased expres-
sion of LC3 and Beclin-1, and conversion from LC3-I to 
LC3-II. It is interesting to note that autophagy seems to be 
the main mode of cell death following 5–10 μmol L1 
LMnAc treatment for 24 h as 3-MA, an inhibitor of au-
tophagy, could almost reduce cell death which was induced 
by 5–10 μmol L1 LMnAc, and partly reduce cell death fol-
lowing 15 μmol L1 LMnAc treatment. Consistent with the 
data, autophagy occurred in the presence of polygonatum 
cyrtonema lectin, adriamycin and many other antitumor 
drugs at low concentrations. Interestingly, apoptosis also 
occurred, indicating apoptosis and autophagy could work 
together to induce cell death [25,47]. Therefore, this study 
strongly supports the fact that LMnAc induces both apop-
totic and autophagic cell death. 
It is well established that mitochondria play a central role 
in the process of cell death, including apoptosis and au-
tophagy [48,49]. Recent findings convincingly point to mi-
tochondria as a highly intriguing, thus far relatively valued 
anticancer target [32]. It has been proposed that mitochon-
dria can regulate the release of proteins inducing apoptosis 
and autophagy through excessive ROS generation and 
self-directed induction of mitochondrial permeability transi-
tion (MPT) [32].  
Moreover, mitochondria are the most important intracel-
lular source of ROS, and it has been proposed that ROS 
could play regulatory roles in mediating cell death with mi-
tochondrial dysfunction [50]. One common feature of can-
cer cells is the increase in ROS generation. Compelling ev-
idence suggests that most cancer cells are under oxidative 
stress associated with increased metabolic activity and pro-
duction of ROS. Excessive ROS accumulation will affect 
MMP and trigger a series of mitochondria-associated events, 
including MPTP opening, cytoplasmic Ca2+ accumulation, 
intracellular ATP level reduction, and MMP collapse [51], 
which would lead to loss of cell function, cell cycle arrest, 
apoptosis and autophagy [50,5254]. Consistent with these 
observations, LMnAc could induce mitochondrial dysfunc-
tion, including MMP collapse, ATP depletion and intracel-
lular free Ca2+ overload, after ROS accumulation. To con-
firm whether ROS is the main reason for cell death, NAC 
was used. The results showed that NAC, a ROS scavenger, 
significantly reduced LMnAc-induced cell death, which 
showed that ROS were involved and may be critical in 
LMnAc-induced cytotoxicity of A549 cells.  
The reduced effects of anticancer drugs are becoming a 
major concern following long-term use of chemotherapy 
agents. This problem may be solved with the use of LMnAc 
because of its induction of both apoptosis and autophagic 
cell death, especially the latter. However, the interaction 
between apoptosis and autophagy following LMnAc treat-
ment remains unclear and requires further research. 
In summary, these findings indicate that the novel Mn 
compound LMnAc is a promising selective anticancer drug 
candidate. LMnAc exhibits potential and stable antiprolifer-
ative effects via inducing cell death triggered by ROS gen-
eration that is mediated through mitochondrial dysfunction.  
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